With only six months left until July 1, 2026, the implementation of Article 75 of the National Medical Products Administration's "Special Regulations on the Registration of Traditional Chinese Medicine" is entering its final window period. This regulation, referred to in the industry as the "death clause" for proprietary Chinese medicines, clearly states that after three years of implementation starting from July 1, 2023, the contraindications in the instructions will be prohibitedWallstreetcn·Jan 27 at 04:41 AM512290+0.60%159929+0.68%
The second-hand recycling price of ZZPZH has plummeted, recyclers say: the market is too saturated, and there is too much inventory on the marketZhitong·Oct 26, 2025 at 01:29 AM600436+2.36%
The market value of the hundred billion is in jeopardy! After a 20% plunge in profits, how will "Chinese medicine Moutai" ZZPZH turn the tide?Wallstreetcn·Oct 24, 2025 at 08:30 AM000538+0.21%03613-0.29%
ZZPZH released its performance for the first three quarters, with a net profit attributable to the parent company of 2.129 billion yuan, a year-on-year decrease of 20.74%Zhitong·Oct 17, 2025 at 05:41 AM600436+2.36%
Cosunter and ZZPZH established a pharmaceutical company with a registered capital of 50 million yuanZhitong·Oct 17, 2025 at 01:39 AM300436+3.42%600436+2.36%
ZZPZH, CICC and others establish new medical industry investment partnershipZhitong·Oct 15, 2025 at 08:06 PM601995+0.34%03908+0.56%
Cosunter and ZZPZH established a pharmaceutical company with a registered capital of 50 millionZhitong·Oct 15, 2025 at 01:31 AM300436+3.42%600436+2.36%
ZZPZH and others established a new materials company in Fujian with a registered capital of 60 millionZhitong·Sep 19, 2025 at 02:17 AM600436+2.36%
ZZPZH released its performance for the first half of the year, with a net profit attributable to the parent company of 1.442 billion yuan, a decrease of 16.22%Zhitong·Aug 29, 2025 at 11:27 AM600436+2.36%
ZZPZH: In the first half of 2025, the net profit was 1.442 billion yuan, a year-on-year decrease of 16.22%Zhitong·Aug 22, 2025 at 05:36 AM600436+2.36%
ZZPZH: Director Lai Wenning resigned due to work adjustment reasonsZhitong·Aug 13, 2025 at 03:22 AM600436+2.36%
ZZPZH's subsidiary plans to invest 200 million yuan in the GaoXin RunXin FundZhitong·Aug 6, 2025 at 06:50 AM600436+2.36%
ZZPZH released its first-quarter performance, with a net profit attributable to the parent company of 1 billion yuan, a year-on-year increase of 2.59%Zhitong·Apr 29, 2025 at 10:07 AM600436+2.36%
ZZPZH released its 2024 annual performance, with a net profit attributable to the parent company of 2.977 billion yuan, a year-on-year increase of 6.42%Zhitong·Apr 25, 2025 at 11:36 AM600436+2.36%
The import of ox bile opens up: The supply chain is expected to become stratified, can the "gold price" myth be broken?Zhitong·Apr 24, 2025 at 07:28 PM600085+0.15%600436+2.36%
